Residron Adverse Reactions

risedronic acid


Mega Lifesciences


Zuellig Pharma
Full Prescribing Info
Adverse Reactions
More than 10%: Cardiovascular: Hypertension (11%).
Central Nervous System: Headache (3-18%).
Dermatologic: Rash (8-12%).
Endocrine and Metabolic: Increased serum parathyroid hormone (PTH) levels (<30%).
Gastrointestinal: Diarrhea (5-20%); nausea (4-13%); constipation (3-13%); abdominal pain (2-12%); dyspepsia (4-11%).
Genitourinary: Urinary tract infection (11%).
Neuromuscular and Skeletal: Arthralgia (7-33%); back pain (6-28%).
Miscellaneous: Infection (≤31%).
1-10%: Cardiovascular: Peripheral edema (8%); chest pain (5-7%); arrhythmia (2%).
Central Nervous System: Depression (7%); dizziness (3-7%).
Endocrine and Metabolic: Hypocalcemia (≤5%); hypophosphatemia (<3%).
Gastrointestinal: Vomiting (2-5%); gastritis (3%); duodenitis (≤1%); glossitis (≤1%).
Genitourinary: Prostatic hyperplasia (5%); nephrolithiasis (3%).
Neuromuscular and Skeletal: Joint disorder (7%); myalgia (2-7%); neck pain (5%); muscle spasm (1-2%).
Ocular: Cataract (7%).
Respiratory: Bronchitis (3-10%); pharyngitis (6%); rhinitis (6%); dyspnea (4%).
Miscellaneous: Flu-like syndrome (10%); acute phase reaction (includes fever, influenza-like illness) (≤8%).
Less than 1%: Limited to Important or Life-Threatening: Diaphyseal femur fracture, dysphagia, esophageal cancer, esophageal ulcer, esophagitis, gastric ulcer, hypersensitivity reaction, musculoskeletal pain (rarely severe or incapacitating), osteonecrosis (primarily of the jaw), subtrochanteric femur fracture (<1%).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in